Member Info for Aldebaran

No warrants no huge discount shares in sticky hands. This is a proper result for avacta and for us holders good im pleased I added 5 grand earlier this week ;)

That alone could be worth 500 grand in the next 12 - 24 months.

P.s. from what I hear these HNW's will be happy taking shares each quarter and hanging onto them. No more heights dilution and dumping. Shares going into sticky hands and as price rises dilution becomes less. Shorter can't attack each quarter now in anticipation of a price drop. This is fantastic news.

I expect GSA will close out now if they haven't been doing already.

These aren't being dumped on the market either :)

Boom!

Ermm..

This is exactly what i told you all would happen btw :)

SGC has no standard of care so its a much easier pathway to accelerated approval. Nothing wrong with STS at all. And the half life issue has been debunked multiple times now. It's not a issue. CC targeting accelerated approval and then watch the off label usage skyrocket. This actually works. It's repeatable and predictable. Ava6000 is a beast in itself

Yep good point JHFH

If the market thought we were about to have 10m shares hit, it would be selling off, no?

Infact, as in previous quarters, shorts would already be loading up. Not seeing any of that this time... wonder why ;-)

This what you call stepping up?

He's been at the helmet forever and delivered nothing but pain for shareholders. We are not a charity.

At this rate i can see share price heading back sub 1p and us having to consolidate again ffs.

Thankfully only got a small pzn here and its not worth chopping it incase this does come good but its just so far away. We'll be diluted to oblivion before anything good happens even if it does happen.

Nice 120k grant though lol

Yes Viking, time to all carp out pants because the no. Of shares is going to increase by 2.5% 😅

If they go into sticky hands, the level of dilution is a drop in the ocean compared to the upside possibilities of many hundred percent gains.

Will this breach £10 per share? Looks like it!

275p I should say. 175p is where it is headed though IMO

Onc again banging in about Avacta. Who are not competitors to audiboom.

They are sat on the IP to a platform technology capable le of revolutionising a TAM worth HUNDREDS of BILLIONS of dollars. Nobody in the world has achieved anything close to what they have, at 30p they are demonstratably chronically undervalued with pre-clinical and clinical stage partnerships and acquisitions happening for more than their entire market cap. There time will come and I am not concerned whatsoever hence the additional £5k investment yesterday. When you understand the IP and USP you understand it is trading significantly below its inherent value.

Will it bag before audiboom? You bet. Infact ill bet it AT LEAST double bags before audiboom does one bag.

7/15/25 AVCT SP 32p, BOOM SP 175p

Major share dilution next week yet price not crashing like it usually does...

Wonder why? Lol

Tell me how to value avacta next week when they have no CLN to worry about for the rest of this year at least?

What are the odds of us signing a commercial deal before cash runs out in Q1 next year?

How will SP respond to more positive trial updates, GSA closing their short, Tr1's filed, coris sold and certain approvals from the FDA ?

A heck of a lot more than 30p per share I can assure you of that!!

Profit and free cash flow are both important financial metrics, but they represent different aspects of a company's financial health. Profit, also known as net income, is the financial performance of a company over a period, reflecting revenue minus expenses. Free cash flow (FCF), on the other hand, represents the cash a company generates after accounting for all operating expenses and capital expenditures. Essentially, profit is an accounting measure, while free cash flow is a measure of cash availability.

Free cash flow is what matters in this type of company hence why directors are always pointing at not only EBITDA but adjusted EBITDA which is ridiculous. All that revenue and no cash to show for it. No USP and in a crowded competitive sector. I don't think things end well for audiboom unless their is a rapid improvement. Maybe that will happen who knows but I don't gamble so ill keep watching and analysing before committing any hard earned cash here. Currently its just a gamble

Don't mention the obvious commee the audiboom zealots don't like it because audioboom is so amazing. Forget the fact they can't convert tens of millions of pounds of revenue into any cash at all. It's all about price to earnings ratio.

Im not sure what avacta are doing. If i had to guess id say they will be consistent and leave the RNS to the 21st so that in future its not easy to predict. Believe it or not CC has our best interests at heart. She has a plan and is executing

Overall funding is a issue yeah but cash to Q1 and Coris to sell so nobody is worried about that YET. What is preventing significant cash inflow is the uncertainty around the CLN. Clarify that and the SP rockets for next few months as investors anticipate a deal during the dealmaking window. If a deal doesn't come by Nov December time then the SP will start to retreat as fears around cash grow.

For now, if the cln is paid in cash, the SP rallies and I fully expect the SP to be paid in cash hence adding today and just not saying I'm adding I actually added and provided my bye details as proove

Avacta have already issued a ton of good news which has not been reflected in the share price and won't be until the threat of dilution each quarter is put to bed. That will be sorted and then whooosh, were off as investors once again start looking forward to actual commercial deals landing.

We can expect gsa to close out out of the blue and can expect ODD for salivary cancer to be awarded out the blue plus Coris sale and more trial data showing partial and even minor responses etc... all to play for here

Zak hits nail on the head there finally.

All about free cash flow as I've said previously. For this type of business model anyway. Hence why directors are deflecting by shouting about "adjusted ebitda". It's all smoke and mirrors and jam tomorrow..